10.08
+0.1(+1.00%)
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
2647
First IPO Date
October 30, 2009
| Name | Title | Pay | Year Born |
| Mr. Jian Ping Yao | Chief Executive Officer | 0 | 1972 |
| Mr. Yinghui Dou | Vice President | 0 | 1984 |
| Ms. Chunyan Lu | Vice President | 0 | 1978 |
| Mr. Yong Bin Wang | Director of Operations & Director | 0 | 1968 |
| Mr. Xueke Bao | Vice President | 0 | 1974 |
| Mr. Hai Sheng | Senior Vice President | 0 | 1975 |
| Mr. Lihua Song Ph.D. | Chairman of Board of Directors & President | 0 | 1957 |
| Mr. Chenghao Hu | Financial Director | 0 | 1976 |
| Ms. Hui Zhao | Senior Vice President & Director | 0 | 1974 |
| Ms. Hongyi Yao | Vice President | 0 | 1972 |
Anhui Anke Biotechnology (Group) Co., Ltd. develops, produces, and markets pharmaceutical products in China and internationally. The company offers recombinant human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name. It also provides anti-sperm antibody, semen leukocyte peroxidase staining, one-time semen processing, sperm hypo-osmotic staining, sperm life detection, sperm staining detection, sperm acrosin detection, sperm DNA fragmentation staining, and leptin and immunohistochemical diagnostic kits. In addition, the company offers adhesive plasters, oral solutions, topical preparations, and ointments; peptide APIs; beauty care and anti-aging products; and synthetic drugs in the form of oral powders, dripping pills, and tablets and capsules. Further, it provides autosomal, sex chromosome, autosomal and sex chromosome combination, and other kits, as well as paternity testing set packages; tumor biological immunotherapy products; and DNA testing professional services. The company was founded in 2000 and is based in Hefei, China.
